Sample | Title | Value | Rank |
GSM780707 | Untreated after 4 days (C1_1) | 40.7806 | 9 |
GSM780708 | Untreated after 4 days (C2_1) | 41.6466 | 12 |
GSM780709 | Untreated after 4 days (C3_1) | 45.3999 | 29 |
GSM780719 | Untreated after 4 days (C1_2) | 46.7077 | 35 |
GSM780720 | Untreated after 4 days (C2_2) | 38.0999 | 3 |
GSM780721 | Untreated after 4 days (C3_2) | 45.3388 | 29 |
GSM780710 | Trastuzumab treated after 4 days (T1_1) | 39.7385 | 6 |
GSM780711 | Trastuzumab treated after 4 days (T2_1) | 43.8901 | 22 |
GSM780712 | Trastuzumab treated after 4 days (T3_1) | 42.4653 | 15 |
GSM780722 | Trastuzumab treated after 4 days (T1_2) | 45.7194 | 31 |
GSM780723 | Trastuzumab treated after 4 days (T2_2) | 41.8526 | 13 |
GSM780724 | Trastuzumab treated after 4 days (T3_2) | 44.9009 | 27 |
GSM780713 | Pertuzumab treated after 4 days (P1_1) | 44.7048 | 26 |
GSM780714 | Pertuzumab treated after 4 days (P2_1) | 43.6062 | 20 |
GSM780715 | Pertuzumab treated after 4 days (P3_1) | 42.0932 | 13 |
GSM780725 | Pertuzumab treated after 4 days (P1_2) | 42.6055 | 16 |
GSM780726 | Pertuzumab treated after 4 days (P2_2) | 48.1627 | 42 |
GSM780727 | Pertuzumab treated after 4 days (P3_2) | 43.8147 | 21 |
GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 45.7169 | 31 |
GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 40.7737 | 9 |
GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 43.8743 | 22 |
GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 41.7045 | 12 |
GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 35.7109 | 1 |